📰 Mark Posno News
Mark Posno News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Mark Posno. Real-time updates on events, politics, business and more.
November 1, 2022
LEIDEN, the Netherlands, November 1, 2022 / B3C newswire / -- ProteoNic BV, a leading provider of premium vector technology and services for efficient production of biologics, today announced the extension of its license agreement with GigaGen, a biotechnology company advancing transformative antibody drug...
November 1, 2022
LEIDEN, Netherlands, Nov. 1, 2022 /PRNewswire/ -- ProteoNic BV, a leading provider of premium vector technology and services for efficient production of biologics, today announced the extension
July 5, 2022
LEIDEN, the Netherlands and BERLIN, Germany, July 05, 2022 / B3C newswire / -- ProteoNic BV, a leading provider of premium vector technology and services for efficient production of biologics, and FyoniBio GmbH, a contract development organization for biopharmaceuticals, today announced they have entered into a...
July 5, 2022
/PRNewswire/ -- ProteoNic BV, a leading provider of premium vector technology and services for efficient production of biologics, and FyoniBio GmbH, a contract...
June 15, 2022
LEIDEN, Netherlands, June 15, 2022 /PRNewswire/ -- ProteoNic BV, a leading provider of premium vector technology and services for efficient production of biologics, today announced licensing
June 15, 2022
LEIDEN, the Netherlands, June 15, 2022 / B3C newswire / -- ProteoNic BV, a leading provider of premium vector technology and services for efficient production of biologics, today announced licensing of its premium 2G UNic™ technology for boosting therapeutic protein production to GenScript ProBio, a global contract...
June 15, 2022
/PRNewswire/ -- ProteoNic BV, a leading provider of premium vector technology and services for efficient production of biologics, today announced licensing of...
April 26, 2022
ProteoNic and NecstGen announce a partnership for the development of improved viral vector manufacturing for gene therapy applications. Both companies, located on the Leiden Bio Science Park, recognise the need to increase viral titres and optimise production processes.
April 26, 2022
LEIDEN, the Netherlands, April 26, 2022 / B3C newswire / -- ProteoNic, a leading provider of premium vector technology and services for efficient production of biologics, and NecstGen, a CDMO and centre of excellence for Cell and Gene Therapy, announce a partnership for the development of improved viral vector manuf...
April 26, 2022
/PRNewswire/ -- ProteoNic, a leading provider of premium vector technology and services for efficient production of biologics, and NecstGen, a CDMO and centre...